How has your agency established a brand identity? Give specific examples of what they have done? What could they do that they are not now doing to cre
June 8, 2020
Adolescent development
June 9, 2020

Assignment:

Assignment:

1. What are some potential risks or drawbacks from changing or expanding the scope of Banner University of Arizona’s (Tucson Arizona) service line, in order to reach new markets?
2. Are there any benefits for doing so?
3. Does the “dog” (organization) wag the “tail” (marketing), or is it the other way around?
Reading:

Francer, J., Izquierdo, J. Z., Music, T., Narsai, K. Nikidis, C., Simmonds, H., & Woods, P. (2014). Ethical pharmaceutical promotion and communications worldwide: codes and regulations. Philosophy, ethics, and humanities in medicine, 9(1), p. 7. Available in the Trident Online Library.
Geangu, I. P., Dumitru, I., & Gârdan, D. (2013). Ethical and legal aspects of marketing activiity in the field of dental healthcare services. Contemporary Readings in Law and Social Justice, 5(2), 904-918.
Gitterman, A. (2013). Ethical issues and practical challenges raised by internal investigations in the life sciences industry. Defense Counsel Journal, 80(4), 372-394
Glied, S., & Oellerich, D. (2014). Two-generation programs and health. The Future of Children, 24(1).
Hancher-Rauch, H., Hicks, L., Mayol, M. H., & Casselman, K. (2013). SAVING YOUR WELLNESS PROGRAM. Journal of Physical Education, Recreation & Dance, 84(6), 29-34.
Hanna, L., Barry, J., B.Sc, Donnelly, R., Hughes, F., M.Pharm, Jones, D., D.Sc, Laverty, G., Ryan, C.,. (2014). Using debate to teach pharmacy students about ethical issues. American Journal of Pharmaceutical Education, 78(3), 57.
Horwitz, J. R., Kelly, B. D., & DiNardo, J. E. (2013). Wellness incentives in the workplace: Cost savings through cost shifting to unhealthy workers. Health Affairs, 32(3), 468-76.
Stichler, Jaynelle F. (2013). Ethical considerations in healthcare design and construction. HERD: Health Environments Research & Design Journal, 6(4), 5-9.
Womack, C. A. (2013). Ethical and epistemic issues in direct-to-consumer drug advertising: Where is patient agency? Medicine, Health Care, and Philosophy, 16(2), 275-80.Assignment: